Vendor, Solna, SWE
Scandinavian Biopharma Holding Ab
UEI ZKASUJ7ZZC98, CAGE AYBAN
1 award and $22,746,941 obligated between September 18, 2024 and June 5, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $22,746,941 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W81XWH20C0137Definitive Contract, September 18, 2024, Not Competed, 1 offers | Army Med Res Acq ActivityDefense Health Agency | This Contract Is for the Development of an E. Coli Vaccine for FDA Approval.NAICS 541714, PSC Q517 | $22,746,941 |
- Product and service codes
- Q517 Pharmacy Services
- Transactions
- 7 across 1 awards